E C Raps
Overview
Explore the profile of E C Raps including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hurst R, Raps E, Zager E, Galetta S, Flamm E
J Stroke Cerebrovasc Dis
. 2015 Oct;
4(1):30-5.
PMID: 26487532
Stroke, the most common life-threatening neurological disease, is a problem encountered frequently in the acute phase. Therapeutic options in this major cause of death and disability have previously been considered...
2.
Chalela J, Raps E, Kasner S
J Stroke Cerebrovasc Dis
. 2007 Sep;
8(5):355-7.
PMID: 17895187
Stroke in patients with cancer is second only to metastasis as a cause of focal neurological deficit. Stroke in this setting is usually linked to mucinous tumors or hematologic malignancies....
3.
Mayer S, Coplin W, Raps E
J Stroke Cerebrovasc Dis
. 2007 Sep;
8(3):183-91.
PMID: 17895162
No abstract available.
4.
Clark W, Raps E, Tong D, Kelly R
Stroke
. 2000 Jun;
31(6):1234-9.
PMID: 10835438
Background And Purpose: The goals of the present study were to assess the efficacy and safety of nalmefene (Cervene) in patients with acute (< or =6 hours) ischemic stroke and...
5.
Nieves D, Bondi E, Wallmark J, Raps E, Seykora J
Cutis
. 2000 Mar;
65(2):89-92.
PMID: 10696560
Scleromyxedema is a rare systemic disorder characterized by cutaneous sclerosis and papulosis, accompanied by deposition of mucin in the skin and other organs. We describe a case of scleromyxedema in...
6.
Lennihan L, Mayer S, Fink M, Beckford A, Paik M, Zhang H, et al.
Stroke
. 2000 Feb;
31(2):383-91.
PMID: 10657410
Background And Purpose: Cerebral blood flow (CBF) is reduced after subarachnoid hemorrhage (SAH), and symptomatic vasospasm is a major cause of morbidity and mortality. Volume expansion has been reported to...
7.
Mohler 3rd E, Delanty N, Rader D, Raps E
Vasc Med
. 1999 Dec;
4(4):269-72.
PMID: 10613632
Stroke is the third leading cause of death in the USA and in the developed world. The beneficial role of cholesterol reduction in decreasing stroke has been uncertain. However, recent...
8.
Detre J, Samuels O, Alsop D, Kasner S, Raps E
J Magn Reson Imaging
. 1999 Nov;
10(5):870-5.
PMID: 10548801
To evaluate the utility of using magnetic resonance imaging (MRI) of cerebral blood flow (CBF) in conjunction with pharmacologic flow augmentation, the authors imaged 14 patients with ischemic symptoms referable...
9.
Kasner S, Chalela J, Luciano J, Cucchiara B, Raps E, McGarvey M, et al.
Stroke
. 1999 Aug;
30(8):1534-7.
PMID: 10436096
Background And Purpose: The aim of our study was to determine whether the National Institutes of Health Stroke Scale (NIHSS) can be estimated retrospectively from medical records. The NIHSS is...
10.
Philips M, Bagley L, Sinson G, Raps E, Galetta S, Zager E, et al.
J Neurosurg
. 1999 Jul;
90(1):65-71.
PMID: 10413157
Object: The authors sought to treat potentially catastrophic intracranial dural and deep cerebral venous thrombosis by using a multimodality endovascular approach. Methods: Six patients aged 14 to 75 years presented...